Contrad Swiss SA

Contrad Swiss is a life sciences company advancing non-invasive solutions in musculoskeletal and aesthetic regenerative medicine, built around SIGMOLECS, a proprietary technology combining peptides with hyaluronic acid that acts directly at the application site. Its portfolio includes medical devices for orthopedics, sports medicine, rheumatology, pain therapy and rehabilitation, along with aesthetic medicine solutions offering quick post-procedure recovery and long-term skin regeneration, with all products manufactured at EU/Swiss facilities.